Correlation Between Centessa Pharmaceuticals and SOUTHERN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and SOUTHERN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and SOUTHERN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and SOUTHERN PER CORP, you can compare the effects of market volatilities on Centessa Pharmaceuticals and SOUTHERN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of SOUTHERN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and SOUTHERN.

Diversification Opportunities for Centessa Pharmaceuticals and SOUTHERN

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Centessa and SOUTHERN is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and SOUTHERN PER CORP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SOUTHERN PER P and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with SOUTHERN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SOUTHERN PER P has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and SOUTHERN go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and SOUTHERN

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 11.8 times more return on investment than SOUTHERN. However, Centessa Pharmaceuticals is 11.8 times more volatile than SOUTHERN PER CORP. It trades about 0.0 of its potential returns per unit of risk. SOUTHERN PER CORP is currently generating about -0.12 per unit of risk. If you would invest  1,683  in Centessa Pharmaceuticals PLC on September 20, 2024 and sell it today you would lose (32.00) from holding Centessa Pharmaceuticals PLC or give up 1.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  SOUTHERN PER CORP

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
SOUTHERN PER P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SOUTHERN PER CORP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, SOUTHERN is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Centessa Pharmaceuticals and SOUTHERN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and SOUTHERN

The main advantage of trading using opposite Centessa Pharmaceuticals and SOUTHERN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, SOUTHERN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SOUTHERN will offset losses from the drop in SOUTHERN's long position.
The idea behind Centessa Pharmaceuticals PLC and SOUTHERN PER CORP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes